PALbociclib CoLlaborative Adjuvant Study: A Randomized Phase III Trial of Palbociclib With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive (HR+) / Human Epidermal Growth Factor Receptor 2
- Bernicker, Eric H. (Key Personnel)
- Chang, Jenny C. (Key Personnel)
- Heyne, Kirk (Key Personnel)
- Niravath, Polly A. (Key Personnel)
- Singh, Monisha (Key Personnel)
Project: Clinical Trial